Elucidating Circular Ribonucleic Acid Mechanisms Associated with Splicing Factor 3 Inhibition in Cervical Cancer.

Amahle Nyalambisa, Babatunde Adebola Alabi, Zodwa Dlamini, Rahaba Marima

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amahle NyalambisaPan African Cancer Research Institute (PACRI), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention, SAMRC Precision Oncology Research Unit (PORU), University of Pretoria, Hatfield, Pretoria 0028, South Africa.ORCID 0000-0001-9678-6797

Babatunde Adebola AlabiPan African Cancer Research Institute (PACRI), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention, SAMRC Precision Oncology Research Unit (PORU), University of Pretoria, Hatfield, Pretoria 0028, South Africa.

Zodwa DlaminiPan African Cancer Research Institute (PACRI), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention, SAMRC Precision Oncology Research Unit (PORU), University of Pretoria, Hatfield, Pretoria 0028, South Africa.ORCID 0000-0002-8012-3646

Rahaba MarimaPan African Cancer Research Institute (PACRI), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention, SAMRC Precision Oncology Research Unit (PORU), University of Pretoria, Hatfield, Pretoria 0028, South Africa.ORCID 0000-0001-5050-7350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer (CCa) is the fourth leading cause of cancer-related deaths among women worldwide, with nearly 90% of cases in low- and middle-income countries, especially in Sub-Saharan Africa. This study explores the roles of circular ribonucleic acids (circRNAs),

Indexed as

RNA, CircularSerine-Arginine Splicing FactorsUterine Cervical NeoplasmsApoptosisCell Line, TumorCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansMicroRNAsTheophyllineMicroRNAsRNA, CircularSerine-Arginine Splicing FactorsTheophyllinealternative splicingcervical cancercircRNA_400029circular ribonucleic acidshsa_circ_0001038splicing factor 3

Identifiers

PMID41303368

DOI10.3390/ijms262210883

PMCPMC12652422

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.